Dr. Sushanth Sreenivasan, MD

Dr. Sreenivasan practices at Wvu Medicine Wheeling Hospital in Wheeling, West Virginia.

Dr. Sreenivasan's NPI, 1053846295, was assigned on April 25, 2017. Dr. Sreenivasan graduated from KASTURBA MEDICAL COLLEGE MANGALORE in 2016. Dr. Sreenivasan holds Pennsylvania license MD472091.

Dr. Sreenivasan's primary practice is Wvu Medicine Wheeling Hospital, at 1 Medical Park, Wheeling, WV 26003 in Ohio County. The practice phone is (304) 243-3124.

Dr. Sreenivasan's primary practice is Wvu Medicine Wheeling Hospital in Wheeling, West Virginia. Dr. Sreenivasan is also affiliated with Long Island Jewish Medical Center. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Sreenivasan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sreenivasan practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sreenivasan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sreenivasan is licensed in Pennsylvania.

CMS data shows 93 Medicare services from Dr. Sreenivasan across 2 procedure codes in 2024, for 108 Medicare patients. Medicare paid $11,231 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Sreenivasan in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sreenivasan's median patient age at 78, with 33% women.

In 2020, Dr. Sreenivasan wrote 66 Medicare Part D claims. Every claim was for a generic drug. They cover 4 drugs, with $1,078 in total drug cost. In 2019, CMS named 131 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Sreenivasan for performance year 2024, reported through an alternative payment model (APM). Dr. Sreenivasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Sreenivasan, published from 2016 to 2025. 2023 was the busiest year, with 2. Dr. Sreenivasan has published most often in Curr Oncol. Dr. Sreenivasan's most frequent co-authors are Yazan Samhouri, MD, Cyrus Mohammad Ali Khan, MD and Maitreyee Rai.

CMS Open Payments shows 3 general payments to Dr. Sreenivasan from 2 drug and device companies from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $41.

Dr. Sreenivasan graduated from KASTURBA MEDICAL COLLEGE MANGALORE in 2016.